BioNTech SE Share Price Today: Live Updates & Key Insights
BioNTech SE share price today is $89.19, up -0.04%. The stock opened at $88.685 against the previous close of $89.31, with an intraday high of $89.56 and low of $87.27.
BioNTech SE Share Price Chart
BioNTech SE
BioNTech SE Share Price Performance
BioNTech SE Institutional Holdings
BioNTech SE Market Status
BioNTech SE Fundamentals
Market Cap 22435.81 M
PB Ratio 1.0119
PE Ratio 0.0
Enterprise Value 5698.21 M
Total Assets 21979.24 M
Volume 1573370
BioNTech SE Company Financials
About BioNTech SE & investment objective
Company Information BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic colorectal and non-small cell lung cancer. In addition, the company engages in the development of oncology drugs under Phase II clinical trial comprising BNT116 for advance non-small cell lung cancer, BNT326/YL202 for multiple solid tumors and advanced/metastatic breast cancer, Autogene cevumeran for advance colorectal cancer, and Gotistobart for platinum-resistant ovarian cancer, as well as Pumitamig for glioblastoma, hepatocellular carcinoma, malignant pleural mesothelioma, neuroendocrine neoplasms, and metastatic pancreatic ductal adenocarcinoma. Further, it develops BNT166 which is Phase II clinical trial for mpox virus; and infectious diseases drugs under Phase 1/2 clinical trial, which include BNT162 + BNT161 for SARS-CoV-2 and influenza, BNT164 for tuberculosis, BNT165 for malaria, and BNT166 for mpox. The company was incorporated in 2008 and is headquartered in Mainz, Germany.
Organisation Biotechnology
Employees 7807
Industry Biotechnology
CEO Dr. Ugur Sahin M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
BioNTech SE FAQs
What is the share price of BioNTech SE today?
The current share price of BioNTech SE is $89.19.
Can I buy BioNTech SE shares in India?
Yes, Indian investors can buy BioNTech SE shares by opening an international trading and demat account with Motilal Oswal.
How to buy BioNTech SE shares in India?
You can easily invest in BioNTech SE shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy BioNTech SE shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of BioNTech SE.
Can I buy fractional shares of BioNTech SE?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of BioNTech SE?
BioNTech SE has a market cap of $22435.81 M.
In which sector does BioNTech SE belong?
BioNTech SE operates in the Biotechnology sector.
What documents are required to invest in BioNTech SE stocks?
To invest, you typically need:
What is the PE and PB ratio of BioNTech SE?
The PE ratio of BioNTech SE is N/A and the PB ratio is 1.01.